Foresite Capital Management IV, LLC Diversified Active

CIK: 0001704132 · Show all filings

Period: Q1 2025 (← Previous) (Next →)

Filing Date: May 15, 2025

Total Value ($000): $111,069 (100.0% shares, 0.0% debt)

Holdings (5)

PHVS Pharvaris N.V. 62.3%

Value ($000) $69,246 Shares 4,410,581 Est. Cost $27.29 Unrealized -38.2%

MAZE Maze Therapeutics Inc 20.9%

Value ($000) $23,252 Shares 2,111,919 Est. Cost $12.04 Unrealized 0.0%

— Lyell Immunopharma, Inc. 7.8%

Value ($000) $8,612 Shares 16,007,999 Est. Cost $8.70 Unrealized —

KURA Kura Oncology, Inc. 6.6%

Value ($000) $7,338 Shares 1,111,882 Est. Cost $20.39 Unrealized -61.8%

RLAY Relay Therapeutics Inc. 2.4%

Value ($000) $2,620 Shares 1,000,000 Est. Cost $7.47 Unrealized -47.6%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
PHVS	Pharvaris N.V.	4,410,581	$69,246	62.3%	$27.29	-38.2%	COM	N69605108
MAZE	Maze Therapeutics Inc	2,111,919	$23,252	20.9%	$12.04	0.0%	COM	578784100
—	Lyell Immunopharma, Inc.	16,007,999	$8,612	7.8%	$8.70	—	COM	55083R104
KURA	Kura Oncology, Inc.	1,111,882	$7,338	6.6%	$20.39	-61.8%	COM	50127T109
RLAY	Relay Therapeutics Inc.	1,000,000	$2,620	2.4%	$7.47	-47.6%	COM	75943R102